All the above-mentioned compounds have shown promising AChE inhibitory activity and have been mentioned as potential therapeutic agent in Alzheimer’s disease [28,29,30,31]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.